B Colaković1, V Colaković-Popović. 1. Clinical Center of Montenegro, Podgoric, Montenegro, Romania. darko.popovic@tradecom.cg.yu
Abstract
OBJECTIVE AND METHOD: To analyze the development of the number of cervical cancer cases and those who died of the disease in Montenegro. We used data on the number of cases and deaths over a eight-year period (2000-2007). RESULTS: In Montenegro 550 women developed cervical cancer in that period, which is 45% of all cancers affecting the female genital organs. In the first five years, the average disease rate was 19.52/100,000, but in the last three years it amounted to 25,61/100,000 (around 24% higher). The trend suggests significant growth. The average mortality rate was 4.2/100,000. The trend suggests very slight growth. The majority of cases were aged between 40 and 49 years (196 cases out of 550 or 35.64%). CONCLUSION: Almost 2/3 of the cases (64.19%) were aged between 40 and 59 years. There is a need to organize screening of the entire female population aged between 20 and 65-70 years. There is also a need to establish a central registry for malignant diseases in Montenegro.
OBJECTIVE AND METHOD: To analyze the development of the number of cervical cancer cases and those who died of the disease in Montenegro. We used data on the number of cases and deaths over a eight-year period (2000-2007). RESULTS: In Montenegro 550 women developed cervical cancer in that period, which is 45% of all cancers affecting the female genital organs. In the first five years, the average disease rate was 19.52/100,000, but in the last three years it amounted to 25,61/100,000 (around 24% higher). The trend suggests significant growth. The average mortality rate was 4.2/100,000. The trend suggests very slight growth. The majority of cases were aged between 40 and 49 years (196 cases out of 550 or 35.64%). CONCLUSION: Almost 2/3 of the cases (64.19%) were aged between 40 and 59 years. There is a need to organize screening of the entire female population aged between 20 and 65-70 years. There is also a need to establish a central registry for malignant diseases in Montenegro.